Download Hennessy's Highlights® March 2024 edition
Hennessy's Highlights® features the latest oncology news From Mike Hennessy Jr, President & CEO of MJH Life Sciences.
The March 2023 issue, available for download below, contains:
- Early Phase Clinical Research Center Poised to Provide New Benefits in Hawaii and Beyond
- Outreach and Engagement: Colleagues Come Together to Improve Community Care
- Tampa General Hospital Cancer Institute Celebrates 2 Years of Growth and Innovation
- Metrics Report: Which of Your Peers Are Trending?
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
